Chemotherapy Drugs
Sunitinib
Trade Name: Sutent ®
Other Name: SU11248
Drug Type:
Sunitinib is a targeted therapy and is a receptor protein-tyrosine kinase inhibitor. It inhibits the actions of vascular endothelial growth factor (VEGF) and is an angiogenesis inhibitor. (For more detail, see "How Sunitinib Works," below.)
What Sunitinib Is Used For:
- Treatment of gastrointestinal stromal tumor (GIST)
- Treatment of advanced renal cell cancer
Note: If a drug has been approved for one use, physicians may elect to use this same drug for other problems if they believe it may be helpful.
How Sunitinib Is Given:
- As a capsule taken by mouth.
- May be taken with or without food. Avoid grapefruit juice.
- The amount of Sunitinib that you will receive depends on several factors, including your general health or other health problems, and the type of cancer or condition you have. Your doctor will determine your exact dosage and schedule.
Sunitinib Side Effects:
Important things to remember about the side effects of Sunitinib:
- You will not get all of the side effects mentioned below.
- Side effects are often predictable in terms of their onset, duration, and severity.
- Side effects are almost always reversible and will go away after therapy is complete.
- Side effects are quite manageable. There are many options to minimize or prevent them.
The following side effects are common (occurring in greater than 30%) for patients taking Sunitinib:
- Fatigue
- Diarrhea
- Nausea and vomiting
- Heartburn
- Taste changes
- Hypertension (high blood pressure)
- Low blood counts. Your white and red blood cells and platelets may temporarily decrease. This can put you at increased risk for infection, anemia and/or bleeding.
- Skin discoloration (possibly due to the drug color - yellow)
The following side effects are less common (occurring in 29-10%) for patients receiving Sunitinib:
- Poor Appetite
- Headache
- Increased liver enzymes
- Weakness
- Constipation
- Abdominal pain
- Bleeding
- Fever
- Dry skin
- Swelling of ankles and feet
- Dizziness
- Increased amylase and lipase levels
- Shortness of breath
- Generalized aches and pains
- Rash
- Flatulence
- Hand –foot syndrome (Palmar-plantar erythrodysesthesia or PPE) –skin rash, swelling, redness, pain and/or peeling of the skin on the palms of hands and soles of feet.
- Dehydration
- Low potassium levels
- Increased bilirubin levels
- Hair color changes
- Cough
- Hair loss
Rare (2-3%) but serious side effects may include problems with blood clots. Blood clots can lead to pulmonary embolus or stroke – potentially life-threatening conditions.
This list includes common and less common side effects for those taking Sunitinib. Side effects that are very rare -- occurring in less than about 10 percent of patients -- are not listed here. But you should always inform your health care provider if you experience any unusual symptoms.When To Contact Your Doctor or Health Care Provider:
Contact your health care provider immediately, day or night, if you should experience any of the following symptoms:
- Fever of 100.5º F (38º C) or higher, chills (possible signs of infection)
The following symptoms require medical attention, but are not an emergency. Contact your health care provider within 24 hours of noticing any of the following:
- Nausea (interferes with ability to eat and unrelieved with prescribed medication).
- Vomiting (vomiting more than 4-5 times in a 24 hour period).
- Diarrhea (4-6 episodes in a 24-hour period).
- Unable to eat or drink for 24 hours or have signs of dehydration: tiredness, thirst, dry mouth, dark and decreased amount of urine, or dizziness.
- Unusual bleeding or bruising
- Black or tarry stools, or blood in your stools.
- Blood in the urine.
- Pain or burning with urination.
- Extreme fatigue (unable to carry on self-care activities).
- Mouth sores (painful redness, swelling or ulcers).
- Swelling, redness and/or pain in one leg or arm and not the other (may be signs and symptoms of blood clot)
Always inform your health care provider if you experience any unusual symptoms.
Sunitinib Precautions:
Sunitinib Self Care Tips:
Monitoring and Testing While Taking Sunitinib:
You will be checked regularly by your doctor while you are taking Sunitinib, to monitor side effects and check your response to therapy. Periodic blood work will be obtained to monitor your complete blood count (CBC) as well as the function of other organs (such as your kidneys and liver) will also be ordered by your doctor.
How Sunitinib Works:
Targeted therapy is the result of about 100 years of research dedicated to understanding the differences between cancer cells and normal cells. To date, cancer treatment has focused primarily on killing rapidly dividing cells because one feature of cancer cells is that divide rapidly. Unfortunately, some of our normal cells divide rapidly too, causing multiple side effects.
Targeted therapy is about identifying other features of cancer cells. Scientists look for specific differences in the cancer cells and the normal cells. This information is used to create a targeted therapy to attack the cancer cells without damaging the normal cells, thus leading to fewer side effects. Each type of targeted therapy works a little bit differently but all interfere with the ability of the cancer cell to grow, divide, repair and/or communicate with other cells.
There are different types of targeted therapies, defined in three broad categories. Some targeted therapies focus on the internal components and function of the cancer cell. These use small molecules that can get into the cell and disrupt the function of the cells, causing them to die. There are several types of targeted therapy that focus on the inner parts of the cells. The second variety target receptors that are on the outside or surface of the cell. This form of targeted treatment includes the monoclonal antibodies. Finally, antiangiogenesis inhibitors target the blood vessels that supply oxygen to the cancer cells, ultimately causing the cells to starve and die.
Sunitinib is designed to block tumor cell growth in several ways. Sunitinib targets several enzymes on blood vessel cells and tumor cells. Several of these targets are thought to be involved in angiogenesis (making of blood vessels).
Research continues to identify which cancers may be best treated with targeted therapies and to identify additional targets for more types of cancer.
Note: We strongly encourage you to talk with your health care professional about your specific medical condition and treatments. The information contained in this website is meant to be helpful and educational, but is not a substitute for medical advice.





